Safety and Efficacy of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler Compared with Fluticasone Propionate/Salmeterol Diskus in Patients with Chronic...

ανά Koser, Andras, Westerman, Jan, Sharma, Sanjay, Emmett, Amanda, Crater, Glenn D
Έκδοση 2010

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk

ανά Covelli, Henry, Pek, Bonavuth, Schenkenberger, Isabelle, Scott-Wilson, Catherine, Emmett, Amanda, Crim, Courtney
Τόπος έκδοσης Int J Chron Obstruct Pulmon Dis (2015)

Disease severity and symptoms among patients receiving monotherapy for COPD

ανά Dransfield, Mark T, Bailey, William, Crater, Glenn, Emmett, Amanda, O'Dell, Dianne M, Yawn, Barbara
Τόπος έκδοσης Prim Care Respir J (2011)

A Patient-Centered Walking Program for COPD

ανά Bender, Bruce G., Depew, Ann, Emmett, Amanda, Goelz, Kelly, Make, Barry, Sharma, Sanjay, Underwood, Jennifer, Stempel, David
Τόπος έκδοσης Chronic Obstr Pulm Dis (2016)

A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD

ανά Crim, Courtney, Gotfried, Mark, Spangenthal, Selwyn, Watkins, Michael, Emmett, Amanda, Crawford, Catriona, Baidoo, Charlotte, Castro-Santamaria, Ramiro
Τόπος έκδοσης BMC Pulm Med (2020)

Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation

ανά Ohar, Jill A, Crater, Glenn D, Emmett, Amanda, Ferro, Thomas J, Morris, Andrea N, Raphiou, Ibrahim, Sriram, Peruvemba S, Dransfield, Mark T
Έκδοση 2014

Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts

ανά Forns, Xavier, Feld, Jordan J., Dylla, Douglas E., Pol, Stanislas, Chayama, Kazuaki, Hou, Jinlin, Heo, Jeong, Lampertico, Pietro, Brown, Ashley, Bondin, Mark, Tatsch, Fernando, Burroughs, Margaret, Marcinak, John, Zhang, Zhenzhen, Emmett, Amanda, Gordon, Stuart C., Jacobson, Ira M.
Τόπος έκδοσης Adv Ther (2021)